SILVERARC CAPITAL MANAGEMENT, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$457.2B
Holdings
61
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (61 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 400,014 | $31.3B | 6.85% | |
| 2 | MRUSMERUS N V | 680,845 | $28.6B | 6.26% | |
| 3 | IM8NINSMED INC | 372,230 | $25.7B | 5.62% | |
| 4 | VRNAVERONA PHARMA PLC | 516,014 | $24.0B | 5.24% | |
| 5 | AKROAKERO THERAPEUTICS INC | 739,563 | $20.6B | 4.50% | |
| 6 | VCYTVERACYTE INC | 503,281 | $19.9B | 4.36% | |
| 7 | ERASERASCA INC | 7,543,901 | $18.9B | 4.14% | |
| 8 | PLRXPLIANT THERAPEUTICS INC | 1,315,601 | $17.3B | 3.79% | |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 1,230,400 | $16.3B | 3.56% | |
| 10 | RNAAVIDITY BIOSCIENCES INC | 543,651 | $15.8B | 3.46% | |
| 11 | RYTMRHYTHM PHARMACEUTICALS INC | 273,896 | $15.3B | 3.35% | |
| 12 | ITCIEURINTRA-CELLULAR THERAPIES INC | 179,085 | $15.0B | 3.27% | |
| 13 | URGNUROGEN PHARMA LTD | 1,120,473 | $11.9B | 2.61% | |
| 14 | CNTACENTESSA PHARMACEUTICALS PLC | 598,952 | $10.0B | 2.19% | |
| 15 | KODKODIAK SCIENCES INC | 1,000,000 | $9.9B | 2.18% | |
| 16 | PSTXUSDPOSEIDA THERAPEUTICS INC | 1,012,307 | $9.7B | 2.13% | |
| 17 | ORICORIC PHARMACEUTICALS INC | 1,178,300 | $9.5B | 2.08% | |
| 18 | TELATELA BIO INC | 3,065,649 | $9.3B | 2.03% | |
| 19 | SRRKSCHOLAR ROCK HLDG CORP | 183,243 | $7.9B | 1.73% | |
| 20 | WVEWAVE LIFE SCIENCES LTD | 608,897 | $7.5B | 1.65% | |
| 21 | COGTCOGENT BIOSCIENCES INC | 921,137 | $7.2B | 1.57% | |
| 22 | ASNDASCENDIS PHARMA A/S | 51,491 | $7.1B | 1.55% | |
| 23 | IRONDISC MEDICINE INC | 110,381 | $7.0B | 1.53% | |
| 24 | TCE2CELLDEX THERAPEUTICS INC NEW | 264,560 | $6.7B | 1.46% | |
| 25 | ELUTELUTIA INC | 1,782,271 | $6.7B | 1.46% | |
| 26 | BDSXBIODESIX INC | 4,332,281 | $6.6B | 1.45% | |
| 27 | —AKERO THERAPEUTICS INC | 220,000 | $6.1B | 1.34% | Call |
| 28 | GOSSGOSSAMER BIO INC | 6,171,847 | $5.6B | 1.22% | |
| 29 | PRAXPRAXIS PRECISION MEDICINES I | 72,516 | $5.6B | 1.22% | |
| 30 | HLXCHELIX ACQUISITION CORP II | 513,369 | $5.4B | 1.18% | |
| 31 | RAREULTRAGENYX PHARMACEUTICAL IN | 124,388 | $5.2B | 1.14% | |
| 32 | KALVKALVISTA PHARMACEUTICALS INC | 612,173 | $5.2B | 1.13% | |
| 33 | TVTXTRAVERE THERAPEUTICS INC | 277,365 | $4.8B | 1.06% | |
| 34 | CCCCC4 THERAPEUTICS INC | 1,221,131 | $4.4B | 0.96% | |
| 35 | GPCRSTRUCTURE THERAPEUTICS INC | 152,395 | $4.1B | 0.90% | |
| 36 | TARSTARSUS PHARMACEUTICALS INC | 65,955 | $3.7B | 0.80% | |
| 37 | INCYINCYTE CORP | 49,000 | $3.4B | 0.74% | |
| 38 | PCVXVAXCYTE INC | 40,788 | $3.3B | 0.73% | |
| 39 | GONGERON CORP | 920,022 | $3.3B | 0.71% | |
| 40 | TRVITREVI THERAPEUTICS INC | 734,234 | $3.0B | 0.66% | |
| 41 | CGENCOMPUGEN LTD | 1,624,377 | $2.5B | 0.54% | |
| 42 | CERSCERUS CORP | 1,587,228 | $2.4B | 0.53% | |
| 43 | SNDXSYNDAX PHARMACEUTICALS INC | 172,400 | $2.3B | 0.50% | Call |
| 44 | ABVXABIVAX SA | 285,120 | $2.1B | 0.46% | |
| 45 | UNCYUNICYCIVE THERAPEUTICS INC | 2,486,709 | $2.0B | 0.43% | |
| 46 | VRDNVIRIDIAN THERAPEUTICS INC | 100,000 | $1.9B | 0.42% | |
| 47 | DCTHDELCATH SYS INC | 155,325 | $1.9B | 0.41% | |
| 48 | QUREUNIQURE NV | 100,000 | $1.8B | 0.39% | |
| 49 | MODDMODULAR MED INC | 1,272,015 | $1.7B | 0.38% | |
| 50 | KALAKALA BIO INC | 231,070 | $1.6B | 0.35% | |
| 51 | NMRANEUMORA THERAPEUTICS INC. | 147,200 | $1.6B | 0.34% | Call |
| 52 | OLMAOLEMA PHARMACEUTICALS INC | 233,281 | $1.4B | 0.30% | |
| 53 | GILDGILEAD SCIENCES INC | 10,000 | $923.7M | 0.20% | |
| 54 | EYPTEYEPOINT PHARMACEUTICALS INC | 121,274 | $903.5M | 0.20% | |
| 55 | RADXRADIOPHARM THERANOSTICS LTD | 187,406 | $841.5M | 0.18% | |
| 56 | ETNBGBP89BIO INC | 96,511 | $754.7M | 0.17% | |
| 57 | VXRTVAXART INC | 1,077,782 | $713.6M | 0.16% | |
| 58 | KPTIEURKARYOPHARM THERAPEUTICS INC | 595,990 | $403.1M | 0.09% | |
| 59 | GUTSFRACTYL HEALTH INC | 176,922 | $364.5M | 0.08% | |
| 60 | BIOABIOAGE LABS INC | 39,974 | $231.4M | 0.05% | |
| 61 | RCKTWROCKET PHARMACEUTICALS INC | 104,828 | $3.6M | 0.00% |